[
  {
    "ts": null,
    "headline": "Why DaVita Stock Got Rocked This Week",
    "summary": "Confirming this, veteran healthcare company DaVita (NYSE: DVA) suffered a hacker ambush in recent days, a situation that spooked many investors.  As a result, according to data compiled by S&P Global Market Intelligence, DaVita's stock price fell by 10% over the holiday-shortened trading week.  DaVita disclosed the incident on Monday in a regulatory filing.",
    "url": "https://finnhub.io/api/news?id=487929ebff099125f4f6a9286bb54049013da911687770185d5f658ac3ea26c1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745014408,
      "headline": "Why DaVita Stock Got Rocked This Week",
      "id": 133970186,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DVA",
      "source": "Yahoo",
      "summary": "Confirming this, veteran healthcare company DaVita (NYSE: DVA) suffered a hacker ambush in recent days, a situation that spooked many investors.  As a result, according to data compiled by S&P Global Market Intelligence, DaVita's stock price fell by 10% over the holiday-shortened trading week.  DaVita disclosed the incident on Monday in a regulatory filing.",
      "url": "https://finnhub.io/api/news?id=487929ebff099125f4f6a9286bb54049013da911687770185d5f658ac3ea26c1"
    }
  },
  {
    "ts": null,
    "headline": "DaVita Inc. (NYSE:DVA): A Case of Limited Growth Potential",
    "summary": "We came across a bearish thesis on DaVita Inc. (NYSE:DVA) on ValueInvestorsClub by Fenkell. In this article, we will summarize the bears’ thesis on DVA. The company’s shares were trading at $147.00 when this thesis was published, vs. the closing price of $140.03 on Apr 17. DVA provides kidney dialysis services for patients suffering from […]",
    "url": "https://finnhub.io/api/news?id=750463004ca1e0932404c4cb84361d64843e639ab4c9df52ec54446f1589b626",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744983700,
      "headline": "DaVita Inc. (NYSE:DVA): A Case of Limited Growth Potential",
      "id": 133970187,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DVA",
      "source": "Yahoo",
      "summary": "We came across a bearish thesis on DaVita Inc. (NYSE:DVA) on ValueInvestorsClub by Fenkell. In this article, we will summarize the bears’ thesis on DVA. The company’s shares were trading at $147.00 when this thesis was published, vs. the closing price of $140.03 on Apr 17. DVA provides kidney dialysis services for patients suffering from […]",
      "url": "https://finnhub.io/api/news?id=750463004ca1e0932404c4cb84361d64843e639ab4c9df52ec54446f1589b626"
    }
  }
]